Using the gold standard of mass spectrometry in tandem with the Cannabix FAIMS prototype device, Graph A and B below show suppression of background matrix allowing the THC peak to be easily recognized.
This demonstrates the capability of the FAIMS device to isolate and detect THC from complex background matrix.
The Company also reports that it has commenced identification of medical device manufacturers in order to implement human factor design (single or dual stage design), verification testing, and develop manufacturing documentation for standardization requirements, as well as create multiple devices for pilot testing.